APD418
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APD418, covering 2023-11-09 to 2023-11-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction [Phase 2]